Cyclic Arg-Gly-Asp Peptide-Labeled Liposomes for Targeting Drug Therapy of Hepatic Fibrosis in Rats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cyclic Arg-Gly-Asp Peptide-Labeled Liposomes for Targeting Drug Therapy of Hepatic Fibrosis in Rats

Published:2007-05-17 Issue:2 Volume:322 Page:560-568
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Du Shi-Lin,Pan Hong,Lu Wei-Yue,Wang Jian,Wu Jian,Wang Ji-Yao

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference34 articles.

1. Effects of a New Bioactive Lipid-Based Drug Carrier on Cultured Hepatic Stellate Cells and Liver Fibrosis in Bile Duct-Ligated Rats

2. Attachment of 99mTc to lipid vesicles containing the lipophilic chelate dipalmitoylphosphatidylethanolamine-DTTA

3. Identification of novel targeting peptides for human ovarian cancer cells using “one-bead one-compound” combinatorial libraries

4. A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells

5. Targeting hepatic stellate cells for cell-specific treatment of liver fibrosis

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives;International Journal of Pharmaceutics;2024-07

2. JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis;Clinical and Molecular Hepatology;2024-04-01

3. Advances in active targeting of ligand-directed polymeric nanomicelles via exploiting overexpressed cellular receptors for precise nanomedicine;RSC Advances;2024

4. Selective inhibition of glycolysis in hepatic stellate cells and suppression of liver fibrogenesis with vitamin A-derivative decorated camptothecin micelles;Acta Biomaterialia;2023-09

5. Nanomaterials for Targeting Liver Disease: Research Progress and Future Perspectives;Nano Biomedicine and Engineering;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3